MetLife Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
MetLife wird ein jährliches Gewinn- und Umsatzwachstum von 19% bzw. 5.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 21.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 15.9% betragen.
Wichtige Informationen
15.7%
Wachstumsrate der Gewinne
19.4%
EPS-Wachstumsrate
Insurance Gewinnwachstum | 9.3% |
Wachstumsrate der Einnahmen | 5.5% |
Zukünftige Eigenkapitalrendite | 16.1% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 19 Aug 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield
Jul 09MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood
Jun 26Increases to CEO Compensation Might Be Put On Hold For Now at MetLife, Inc. (NYSE:MET)
Jun 12MetLife (NYSE:MET) Is Increasing Its Dividend To $0.545
Apr 27MetLife: Healthy But Lacks Clear Advantages
Apr 18MetLife, Inc.'s (NYSE:MET) P/E Is On The Mark
Apr 18MetLife: A Safe Bet To Hold As Future Earnings Growth Expected, And Tailwind From Rate Environment
Feb 03MetLife: Expected Net Investment Growth For Upcoming Earnings
Jan 26MetLife, Inc.'s (NYSE:MET) P/S Is On The Mark
Jan 15MetLife: Strong Capital Returns Make Shares Attractive (Ratings Upgrade)
Nov 15MetLife: Disappointing Growth But Safe Dividend
Oct 26MetLife: Neutral Rating Maintained, As Stock Remains Overvalued
Aug 18MetLife: An Investment That Ensures Portfolios
Jul 12MetLife institutional asset management arm to acquire Raven Capital
Feb 07MetLife Q4 2022 Earnings Preview
Jan 31MetLife declares $0.50 dividend
Jan 10MetLife Is Trading Favorably On The Market
Dec 24Looking Past Interest Rate Volatility Reveals MetLife Is A Hold
Oct 11MetLife to acquire ESG-focused fixed income manager, Affirmative Investment
Aug 29MetLife: Investors Should Look Past The Noisy Q2 2022 Results
Aug 12MetLife declares $0.50 dividend
Jul 11MetLife Is Well-Positioned For 2022 (And Beyond)
Jun 06MetLife (NYSE:MET) Is Increasing Its Dividend To US$0.50
May 06Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 79,929 | 6,321 | N/A | 9,099 | 6 |
12/31/2025 | 76,491 | 6,085 | 4,400 | 9,096 | 7 |
12/31/2024 | 73,203 | 5,013 | N/A | 8,708 | 7 |
6/30/2024 | 68,770 | 2,708 | 14,475 | 14,475 | N/A |
3/31/2024 | 67,570 | 2,166 | 14,023 | 14,023 | N/A |
12/31/2023 | 66,901 | 1,380 | 13,721 | 13,721 | N/A |
9/30/2023 | 63,479 | 2,355 | 10,840 | 10,840 | N/A |
6/30/2023 | 69,896 | 3,031 | 11,675 | 11,675 | N/A |
3/31/2023 | 68,747 | 3,542 | 13,030 | 13,030 | N/A |
12/31/2022 | 68,764 | 5,099 | 13,044 | 13,044 | N/A |
9/30/2022 | 73,251 | 4,726 | 16,083 | 16,083 | N/A |
6/30/2022 | 67,873 | 5,149 | 15,279 | 15,279 | N/A |
3/31/2022 | 70,923 | 7,634 | 13,140 | 13,140 | N/A |
12/31/2021 | 68,688 | 6,654 | 12,347 | 12,347 | N/A |
9/30/2021 | 70,409 | 5,301 | 12,409 | 12,409 | N/A |
6/30/2021 | 69,519 | 4,413 | 12,696 | 12,696 | N/A |
3/31/2021 | 65,094 | 1,115 | 11,288 | 11,288 | N/A |
12/31/2020 | 67,842 | 5,191 | 11,639 | 11,639 | N/A |
9/30/2020 | 65,567 | 5,603 | 11,667 | 11,667 | N/A |
6/30/2020 | 68,230 | 7,122 | 12,020 | 12,020 | N/A |
3/31/2020 | 71,628 | 8,738 | 13,561 | 13,561 | N/A |
12/31/2019 | 69,620 | 5,721 | 13,786 | 13,786 | N/A |
9/30/2019 | 68,139 | 7,195 | 9,906 | 9,906 | N/A |
6/30/2019 | 65,750 | 5,923 | 9,293 | 9,293 | N/A |
3/31/2019 | 69,438 | 5,084 | 12,514 | 12,514 | N/A |
12/31/2018 | 67,941 | 4,982 | 11,738 | 11,738 | N/A |
9/30/2018 | 68,112 | 5,244 | 12,487 | 12,487 | N/A |
6/30/2018 | 67,980 | 5,235 | 13,688 | 13,688 | N/A |
3/31/2018 | 62,119 | 5,197 | N/A | 11,481 | N/A |
12/31/2017 | 62,308 | 4,893 | N/A | 12,283 | N/A |
9/30/2017 | 59,263 | 1,893 | N/A | 15,876 | N/A |
6/30/2017 | 58,908 | 2,044 | N/A | 14,069 | N/A |
3/31/2017 | 57,263 | 2,229 | N/A | 14,959 | N/A |
12/31/2016 | 60,732 | 3,481 | N/A | 14,774 | N/A |
9/30/2016 | 65,209 | 4,994 | N/A | 13,733 | N/A |
6/30/2016 | 67,255 | 5,169 | N/A | 13,445 | N/A |
3/31/2016 | 69,952 | 5,219 | N/A | 13,356 | N/A |
12/31/2015 | 61,257 | 3,891 | N/A | 14,052 | N/A |
9/30/2015 | 71,888 | 5,857 | N/A | 14,953 | N/A |
6/30/2015 | 72,677 | 6,724 | N/A | 16,343 | N/A |
3/31/2015 | 74,596 | 7,017 | N/A | 16,578 | N/A |
12/31/2014 | 73,265 | 6,190 | N/A | 16,376 | N/A |
9/30/2014 | 72,639 | 5,576 | N/A | 17,097 | N/A |
6/30/2014 | 70,514 | 4,452 | N/A | 15,738 | N/A |
3/31/2014 | 68,330 | 3,586 | N/A | 15,882 | N/A |
12/31/2013 | 69,396 | 3,244 | N/A | 16,131 | N/A |
9/30/2013 | 68,313 | 2,433 | N/A | 11,856 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: METDas prognostizierte Gewinnwachstum (19% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: METDie Erträge des Unternehmens (19% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.8% pro Jahr).
Hohe Wachstumserträge: METDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: METDie Einnahmen des Unternehmens (5.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: METDie Einnahmen des Unternehmens (5.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: METDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (15.9%).